Press releases 13 Feb 2025 DNDi announces organizational strategy update and strengthened executive team
In the media 12 Feb 2025 «Das ist historisch»: Medikament könnte erstmals Infektionskrankheit ausrotten Tages Anzeiger
Statements 12 Feb 2025 DNDi statement on recent US government executive actions and the escalating retreat from global health and medical research
Press releases 10 Feb 2025 The African Union Commission Strengthens Collaboration with the Drugs for Neglected Diseases initiative
In the media 8 Feb 2025 ‘The tsetse fly is attracted to the color blue’: How Guinea has managed to eliminate sleeping sickness as a public health problem El País
In the media 6 Feb 2025 RDC : 340 cas de la trypanosomiase humaine africaine enregistrés en 2024 Agence Congolaise de Presse
Press releases 4 Feb 2025 Hyundai Bio (HDB) and DNDi sign MOU for joint development of Xafty-based dengue treatment
In the media 1 Feb 2025 “C’est une très bonne nouvelle” : la Guinée élimine à son tour “la maladie du sommeil” et nourrit l’espoir d’une éradication mondiale franceinfo
In the media 30 Jan 2025 Enfermedad de Chagas: más del 70% de los afectados desconocen su condición Infobae
In the media 30 Jan 2025 Guinea has wiped out sleeping sickness – will the rest of Africa follow? The Telegraph
Press releases 13 Feb 2025 DNDi announces organizational strategy update and strengthened executive team
Press releases 10 Feb 2025 The African Union Commission Strengthens Collaboration with the Drugs for Neglected Diseases initiative
Press releases 4 Feb 2025 Hyundai Bio (HDB) and DNDi sign MOU for joint development of Xafty-based dengue treatment
Press releases 30 Jan 2025 DNDi welcomes GHIT support for new collaboration with Eisai for dengue and Zika virus disease
Press releases 30 Jan 2025 IRD, DNDi and Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa